stockrow
Saturday 7 November 2026
Export CDT’s income statement to Excel — free account
CDT Equity Inc.
- EPS
- +99.9%
- Free cash flow
- +78.9%
Quarter to June 2026, against a year earlier
1.31
0.46
+54.12%
Follow CDT
Alert me
CDT Equity Inc. (CDT) P/E ratio
CDT Equity Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 1,551× (January 2024) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
Low 0.0×
High 1,551×
Ten-year median
0.0×
Current reading's percentile
94
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SPRC SciSparc Ltd. compare | n/m |
| MLEC Moolec Science SA compare | n/m |
| JAGX Jaguar Animal Health, Inc. compare | n/m |
| VINC Vincerx Pharma, Inc. compare | n/m |
| VRPX Virpax Pharmaceuticals, Inc. compare | n/m |
| CDT CDT Equity Inc. | n/m |
| ATXI Avenue Therapeutics, Inc. compare | n/m |
| LNAI Lunai Bioworks Inc. compare | n/m |
| SCNI Scinai Immunotherapeutics Ltd. Sponsored ADR compare | 0.0× |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)